Targeting Anhedonia in Cocaine Use Disorder
Targeting Anhedonia in Cocaine Use Disorder - Treatment Study
Sponsor: The University of Texas Health Science Center, Houston
This PHASE2 trial investigates Anhedonia and Cocaine-Related Disorders and is currently completed. The University of Texas Health Science Center, Houston leads this study, which shows 12 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
Status: Recruiting → Completed
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2
Status: Unknown Status → Recruiting
-
May 2024 — Jul 2024 [monthly]
Unknown Status PHASE2
Status: Recruiting → Unknown Status
-
May 2022 — May 2024 [monthly]
Recruiting PHASE2
-
Jan 2021 — May 2022 [monthly]
Recruiting PHASE2
▶ Show 7 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Nov 2018 — Dec 2020 [monthly]
Recruiting PHASE2
-
Jul 2018 — Nov 2018 [monthly]
Recruiting PHASE2
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE2
-
Nov 2017 — Jun 2018 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting · Phase: NA → PHASE2
-
Feb 2017 — Nov 2017 [monthly]
Not Yet Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- The University of Texas Health Science Center, Houston
- University of Illinois at Chicago
For direct contact, visit the study record on ClinicalTrials.gov .